Siv Jönsson
Uppsala Universitet
H-index: 23
Europe-Sweden
Top articles of Siv Jönsson
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Characterization of anti-drug antibody dynamics using a bivariate mixed hidden-markov model by nonlinear-mixed effects approach | Journal of Pharmacokinetics and Pharmacodynamics | Ari Brekkan Rocío Lledo-Garcia Brigitte Lacroix Siv Jönsson Mats O Karlsson | 2024/2 |
Therapeutic drug monitoring of vancomycin and meropenem: Illustration of the impact of inaccurate information in dose administration time | International Journal of Antimicrobial Agents | Maria Swartling Thomas Tängdén Miklos Lipcsey Siv Jönsson Elisabet I Nielsen | 2024/1/1 |
A model‐based approach leveraging in vitro data to support dose selection from the outset: A framework for bispecific antibodies in immuno‐oncology | CPT: Pharmacometrics & Systems Pharmacology | Javier Sánchez Christina Claus Rosmarie Albrecht Brenda C Gaillard Joana Marinho | 2023/11 |
A multistate modeling and simulation framework to learn dose–response of oncology drugs: Application to bintrafusp alfa in non‐small cell lung cancer | CPT: Pharmacometrics & Systems Pharmacology | Han Liu Ana‐Marija Milenković‐Grišić Sreenath M Krishnan Siv Jönsson Lena E Friberg | 2023/11 |
Relationship between factor VIII levels and bleeding for rFVIII‐SingleChain in severe hemophilia A: A repeated time‐to‐event analysis | CPT: Pharmacometrics & Systems Pharmacology | Laura H Bukkems Siv Jönsson Marjon H Cnossen Mats O Karlsson Ron AA Mathôt | 2023/5 |
Association between sports participation, factor VIII levels and bleeding in hemophilia A | Thrombosis and haemostasis | Laura H Bukkems Olav Versloot Marjon H Cnossen Siv Jönsson Mats O Karlsson | 2023/3 |
A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study | The Lancet | Jesse J Swen Cathelijne H van der Wouden Lisanne EN Manson Heshu Abdullah-Koolmees Kathrin Blagec | 2023/2/4 |
Population pharmacokinetic analysis of etrolizumab in patients with moderately‐to‐severely active ulcerative colitis | CPT: Pharmacometrics & Systems Pharmacology | Anita Moein Tong Lu Siv Jönsson Jakob Ribbing Nastya Kassir | 2022/9 |
Model-based characterization of the bidirectional interaction between pharmacokinetics and tumor growth dynamics in patients with metastatic Merkel cell carcinoma treated with … | Clinical Cancer Research | Ana-Marija Grisic Wenyuan Xiong Lénaïg Tanneau Siv Jönsson Lena E Friberg | 2022/4/1 |
Population pharmacokinetics of cefotaxime in intensive care patients | European journal of clinical pharmacology | Maria Swartling Anna-Karin Smekal Mia Furebring Miklos Lipcsey Siv Jönsson | 2021/10/1 |
Detecting placebo and drug effects on Parkinson's disease symptoms by longitudinal item‐score models | CPT: Pharmacometrics & Systems Pharmacology | Chao Chen Siv Jönsson Shuying Yang Elodie L Plan Mats O Karlsson | 2021/4 |
Pharmacometrics-based considerations for the design of a pharmacogenomic clinical trial assessing irinotecan safety | Pharmaceutical research | Iris K Minichmayr Mats O Karlsson Siv Jönsson | 2021/4 |
Generating evidence for precision medicine: considerations made by the Ubiquitous Pharmacogenomics Consortium when designing and operationalizing the PREPARE study | Pharmacogenetics and Genomics | Cathelijne H van der Wouden Stefan Böhringer Erika Cecchin Ka-Chun Cheung Cristina Lucía Dávila-Fajardo | 2020/8/1 |
A novel, enriched population pharmacokinetic model for recombinant factor VIII-Fc fusion protein concentrate in hemophilia A patients | Thrombosis and haemostasis | Laura H Bukkems Jessica M Heijdra Mary Mathias Peter W Collins Charles RM Hay | 2020/5 |
Relationship between factor VIII activity, bleeds and individual characteristics in severe hemophilia A patients | haematologica | João A Abrantes Alexander Solms Dirk Garmann Elisabet I Nielsen Siv Jönsson | 2020/5 |
Body mass index best predicts recovery of recombinant factor VIII in underweight to obese patients with severe haemophilia A | Thrombosis and Haemostasis | Andreas Tiede Ana Rosa Cid Georg Goldmann Victor Jiménez-Yuste Michael Pluta | 2020/2 |
Co-Authors
